900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Adverse reaction to ampicillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amylobarbitone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anaesthetic	Ambiguous
Adverse reaction to analeptic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to analeptics NOS	Limited component (foundation metadata concept)
Adverse reaction to analgesics &/or antipyretics &/or antirheumatics	Ambiguous
Adverse reaction to analgesics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to analgesics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to analgesics, anti-pyretics and anti-rheumatics NOS	Limited component (foundation metadata concept)
Adverse reaction to androgen or anabolic steroid NOS	Limited component (foundation metadata concept)
Adverse reaction to androgens and anabolic steroids	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anesthetic	Ambiguous
Adverse reaction to angiotensin converting enzyme inhibitor	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to angiotensin converting enzyme inhibitor	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antacids and antigastric secretion drugs	Ambiguous
Adverse reaction to antacids and antigastric secretion drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to anterior pituitary hormone NOS	Limited component (foundation metadata concept)
Adverse reaction to anterior pituitary hormones	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anti-infective NOS	Classification derived component
Adverse reaction to anti-infective NOS	Classification derived component
Adverse reaction to anti-infective and other drugs and preparations for ear, nose and throat	Ambiguous
Adverse reaction to anti-infective substance	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiallergic and antiemetic drugs	Ambiguous
Adverse reaction to antiallergic and antiemetic drugs NOS	Ambiguous
Adverse reaction to antiasthmatic NOS	Classification derived component
Adverse reaction to antibiotic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antibiotic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antibiotic NOS	Limited component (foundation metadata concept)
Adverse reaction to anticholinesterase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anticoagulant antagonist NOS	Limited component (foundation metadata concept)
Adverse reaction to anticoagulants	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anticoagulants NOS	Limited component (foundation metadata concept)
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS	Classification derived component
Adverse reaction to anticonvulsants NOS	Limited component (foundation metadata concept)
Adverse reaction to anticonvulsants and anti-parkinsonism drugs	A component that fails to comply with the current editorial guidance.
Adverse reaction to antidepressant	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antidepressants NOS	Limited component (foundation metadata concept)
Adverse reaction to antidiarrheal drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antidiarrheal drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to antidotes and chelating agents NEC	Ambiguous
Adverse reaction to antifungal antibiotics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antifungal antibiotics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antifungal antibiotics NOS	Limited component (foundation metadata concept)
Adverse reaction to antihelminthic NOS	Limited component (foundation metadata concept)
Adverse reaction to antihelminthics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antihelminthics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antihypertensives NOS	Limited component (foundation metadata concept)
Adverse reaction to antilipemic and anti-arteriosclerotic drugs	Ambiguous
Adverse reaction to antilipemic and antiarteriosclerotic drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to antilymphocyte immunoglobulin	Ambiguous
Adverse reaction to antimalarials	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimalarials NOS	Limited component (foundation metadata concept)
Adverse reaction to antimony compound	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimycobacterial antibiotic NOS	Limited component (foundation metadata concept)
Adverse reaction to antimycobacterial antibiotics	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimycobacterial drug NOS	Limited component (foundation metadata concept)
Adverse reaction to antineoplastic and immunosuppressive drugs	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antineoplastic and immunosuppressive drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to antineoplastic antibiotics NOS	Limited component (foundation metadata concept)
Adverse reaction to antiparkinsonism drug	A component that fails to comply with the current editorial guidance.
Adverse reaction to antiparkinsonism drugs NOS	Classification derived component
Adverse reaction to antiprotozoal drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiprotozoal drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiprotozoal drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to antirheumatics NOS	Limited component (foundation metadata concept)
Adverse reaction to antithyroid agents	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antithyroid agents NOS	Limited component (foundation metadata concept)
Adverse reaction to antitussive NOS	Limited component (foundation metadata concept)
Adverse reaction to antitussives	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antivaricose drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antivaricose drugs NOS	Limited component (foundation metadata concept)
Adverse reaction to antiviral drug NOS	Limited component (foundation metadata concept)
Adverse reaction to antiviral drugs	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiviral drugs	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aromatic analgesics NEC	Limited component (foundation metadata concept)
Adverse reaction to aromatic analgesics NOS	Limited component (foundation metadata concept)
Adverse reaction to aspirin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aspirin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to atenolol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to atropine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to auranofin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to avomine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to azathioprine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to azlocillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bacampicillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to barbiturate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to barbiturate NOS	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beclamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bendrofluazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to benzhexol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to benzodiazepine-based tranquilizer (finding)	Ambiguous
Adverse reaction to benzodiazepine-based tranquilizer NOS (disorder)	Ambiguous
Adverse reaction to benztropine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bephenium	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers NOS	Limited component (foundation metadata concept)
Adverse reaction to betamethasone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bethanidine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bezafibrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to biguanide oral hypoglycemic agent	A component that fails to comply with the current editorial guidance.

Start Previous Page 76 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)